Title: 17α-alkynyl 3α, 17β-androstanediol non-clinical and clinical pharmacology, pharmacokinetics and metabolism.
Journal: Investigational new drugs 20120201
Title: HE3235 inhibits growth of castration-resistant prostate cancer.
Journal: Neoplasia (New York, N.Y.) 20091101
Title: Inhibition of androstenediol-dependent LNCaP tumour growth by 17alpha-ethynyl-5alpha-androstane-3alpha, 17beta-diol (HE3235).
Journal: British journal of cancer 20090407